Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 674

Results For "AP"

6853 News Found

Govt. monitoring supply of COVID-19 essential drugs
News | May 21, 2021

Govt. monitoring supply of COVID-19 essential drugs

Availability of drugs is being monitored by implementing a three-pronged strategy of supply chain management, demand side management, and affordability.


Cipla launches Covid-19 RT-PCR test Viragen
News | May 21, 2021

Cipla launches Covid-19 RT-PCR test Viragen

This test is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in the upper and lower respiratory specimens from individuals suspected of COVID-19


Dishman Carbogen Amcis announces successful results for treatment for vitamin D deficiency
News | May 21, 2021

Dishman Carbogen Amcis announces successful results for treatment for vitamin D deficiency

Researchers observed that a form of vitamin D, known as 25-hydroxyvitamin D3 (Calcifediol), was absorbed faster and better than the same dose of vitamin D.


Remdesivir production increased to 119 lakh vials per month
News | May 18, 2021

Remdesivir production increased to 119 lakh vials per month

Number of approved manufacturing sites of Remdesivir in the country has increased from 22 sites to 60


NATCO signs licensing agreement with Lilly for Baricitinib
News | May 18, 2021

NATCO signs licensing agreement with Lilly for Baricitinib

Natco has withdrawn its application filed with the Indian Patent Office, seeking Compulsory License against Lilly for Baricitinib for Covid-19 in India


Shilpa Medicare to produce 50 mn doses of Sputnik V Vaccine
News | May 18, 2021

Shilpa Medicare to produce 50 mn doses of Sputnik V Vaccine

Targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production


Outlook promising for Cipla: HDFC Securities
News | May 18, 2021

Outlook promising for Cipla: HDFC Securities

The outlook for the US business remains good as respiratory pipeline (gAbraxane, gAdvair, gDulera) adds medium-term growth visibility.


Sputnik V launch to lift near-term outlook for Dr. Reddy's Labs: HDFC Securities
News | May 18, 2021

Sputnik V launch to lift near-term outlook for Dr. Reddy's Labs: HDFC Securities

Dr. Reddy's has the rights to distribute 250mn doses in India


Outlook intact for Dr. Reddy's Laboratories : ICICI Securities
News | May 18, 2021

Outlook intact for Dr. Reddy's Laboratories : ICICI Securities

India sales grew 23.5% YoY with consolidation of Wockhardt products


Cadila Healthcare divests animal health business: ICICI Securities
News | May 16, 2021

Cadila Healthcare divests animal health business: ICICI Securities

The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.